Home › Funds › Samsara BioCapital, LLC › KLRS

Samsara BioCapital, LLC position in KLRS

KALARIS THERAPEUTICS INC · Health Care

Samsara BioCapital, LLC reported holding 12,881,175 shares of KLRS (KALARIS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$52.4M, representing 4.31% of its reported portfolio and ranking #7 among its reported holdings. Samsara BioCapital, LLC has disclosed KLRS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)12.88M sh
Reported value held$52.43M
Portfolio Weight4.31%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's KLRS position evolved

Samsara BioCapital, LLC first disclosed a stake in KLRS in Q1 2025 at 11,448,081 shares (US$91.9M). The position peaked in Q4 2025 at 12,948,081 shares, worth US$109.3M. Across 6 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 12,881,175 shares valued at US$52.4M — a reduction of -66,906 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 11.45M $91.93M New
Q2 2025 11.45M $30.57M Hold
Q3 2025 11.45M $66.17M Hold
Q4 2025 12.95M $109.28M Add
Q1 2026 12.95M $74.71M Hold
Q2 2026 12.88M $52.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KLRS and 13F data

KLRS (KALARIS THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in KLRS — the largest reported positions include WHI TRUST Co LLC (US$397K), Velan Capital Investment Management LP (US$102K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KLRS

All KLRS fund holders →

FAQ

How long has Samsara BioCapital, LLC held KLRS?

Samsara BioCapital, LLC has disclosed KLRS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Samsara BioCapital, LLC's current position in KLRS?

As of Q2 2026, Samsara BioCapital, LLC holds 12.88M shares of KLRS (KALARIS THERAPEUTICS INC), valued at $52.43M, representing 4.31% of its reported portfolio and ranking #7.

Has Samsara BioCapital, LLC been buying or selling KLRS?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC reduced its position in KLRS. The position peaked in Q4 2025 at 12.95M shares.

Which other funds hold KLRS?

Other major institutional holders of KLRS include WHI TRUST Co LLC, Velan Capital Investment Management LP, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.